Equities

China Pharma Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

China Pharma Holdings Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.6339
  • Today's Change0.001 / 0.09%
  • Shares traded7.94k
  • 1 Year change-70.65%
  • Beta1.2101
Data delayed at least 15 minutes, as of Feb 17 2026 20:12 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

China Pharma Holdings Inc is a company principally engaged in the development, manufacture, and marketing of pharmaceutical products for human use. The Company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The Company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The Company's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The Company mainly operates in the domestic market.

  • Revenue in USD (TTM)4.05m
  • Net income in USD-3.19m
  • Incorporated1999
  • Employees224.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Universe Pharmaceuticals Inc17.86m-3.67m1.61m216.00--0.0287--0.0902-10.13-10.1339.1899.640.26025.881.3882,679.35-5.35-5.40-7.08-7.0935.2843.33-20.56-9.653.90-17.460.1416---22.44-10.2757.92--46.30--
Stemcell Holdings Inc9.98m3.10m1.64m------0.50080.16450.000080.000080.00030.00021.12--5.20--34.90--68.19--77.19--31.04------0.00--85.10--71.82------
Panacea Life Sciences Holdings Inc2.76m-7.67m1.90m40.00------0.6858-0.4554-0.45540.164-0.52550.15371.6210.1369,098.25-42.65-69.04---225.03-139.49-181.62-277.51-505.410.0285-2.122.58--46.59--12.33------
Bio Essence Corp565.67k-160.45k2.08m2.00------3.67-0.0042-0.00420.0149-0.08161.26--16.06282,835.00-35.64-40.94----69.2838.36-28.36-134.00---57.42-------17.08-286.98------
InVitro International716.89k6.22k2.21m16.00284.003.09--3.090.00040.00040.04020.03211.15------0.9957.891.098.83----0.86765.90---------5.111.33-87.77-16.14----
PRF Technologies Ltd0.00-4.09m2.32m2.000.00980.1412----301.27301.270.0020.970.00----0.00-57.27-71.03-118.06-84.02------------0.00-------56.12------
Scisparc Ltd-100.00bn-100.00bn2.59m2.00---------------1.46-----------63.15---90.87-------456.810.5151--1.04---54.64---22.69------
SOHM Inc-100.00bn-100.00bn2.60m--------------------------------------------------------------
Jaguar Health Inc11.79m-40.29m2.87m49.00--0.7415--0.2433-54.06-54.0612.981.530.21840.20998.78240,510.20-76.04-90.27-152.77-144.3681.9275.33-348.22-458.250.5197-4.620.8759--19.7515.146.80------
China Pharma Holdings Inc4.05m-3.19m3.18m224.00--0.3825--0.7849-1.10-1.101.281.660.27692.1714.5218,090.54-21.80-18.69-35.67-37.95-10.94-1.14-78.72-44.960.1026-30.500.2884---35.41-16.15-53.84--16.49--
CYANOTECH CORP25.27m-1.78m3.25m83.00--0.403317.210.1287-0.2469-0.24693.511.091.052.2112.81304,433.80-7.41-6.08-13.42-8.0532.0032.26-7.03-6.370.2988-1.470.5089--4.96-5.3639.19--1.97--
Functional Brands Inc6.80m-377.56k3.44m32.00--2.47--0.5067-0.0546-0.05460.96140.08540.88730.352737.24212,408.80-4.93---9.96--91.06---5.55--0.4419-0.87230.6346---3.72--54.93------
60 Degrees Pharmaceuticals Inc1.35m-8.48m4.52m3.00------3.34-23.04-23.042.934.320.19191.592.71451,383.30-113.08---148.26--42.47---589.17--2.63-44.070.0342--168.70---111.48------
Data as of Feb 17 2026. Currency figures normalised to China Pharma Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

1.19%Per cent of shares held by top holders
HolderShares% Held
Citadel Securities LLCas of 30 Sep 202530.43k0.61%
DRW Securities LLCas of 31 Dec 202517.42k0.35%
Renaissance Technologies LLCas of 31 Dec 202511.32k0.23%
UBS Securities LLCas of 31 Dec 2025513.000.01%
Danske Bank A/S (Investment Management)as of 31 Dec 20251.000.00%
Tower Research Capital LLCas of 30 Sep 20250.000.00%
JPMorgan Securities LLC (Investment Management)as of 31 Dec 20250.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.